Effective protection against PRRSV NADC30 by recombinant chimpanzee adenovirus vaccines expressing GP35 or M-GP5 fusion proteins. Liu C, Ma P, Li J, Li W, et al. Vaccine 2026;92:129158.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu C, Ma P, Li J, Li W, et al. Effective protection against PRRSV NADC30 by recombinant chimpanzee adenovirus vaccines expressing GP35 or M-GP5 fusion proteins. Vaccine 2026;92:129158.
PMID: 42727398